Competitive advantage of our technology
Our patented technology improves the critical currents and irreversibility fields of MgB2 wires significantly, enabling 1.5T and 3.0T MgB2-magnet based MRI! With the NSF (National Science Foundation) SBIR (Small Business Innovation Research) funding, and supported by the PR Science Trust, we have successfully proved the feasibility and scalability of this technology.
The following figure shows the competitive advantages of our technology. The in-situ technique leads to better results in short wires, but it is not promising for 1km - 5km long MgB2 wires for MRI.
The following figure shows the competitive advantages of our technology. The in-situ technique leads to better results in short wires, but it is not promising for 1km - 5km long MgB2 wires for MRI.
Comparison of MgB2 wire test results with other company
INVENTION OF TESTARDI CORRELATION
DR. YONG-JIHN KIM, PRESIDENT AND CEO, IDENTIFIED THE SUPERCONDUCTING MECHANISM OF MGB2, THE MOST IMPORTANT SCIENTIFIC PROBLEM, BY INVENTING TESTARDI CORRELATION.
Image from C. Buzea and T. Yamashita, Supercond. Sci. Technol.14, R115-R146, (2001).
Image from C. Buzea and T. Yamashita, Supercond. Sci. Technol.14, R115-R146, (2001).
Patents:
Our patented technology for Next Generation Cryogenic-free 1.5T and 3.0T MRI
It will revolutionize the MRI Market and NMR Market!
It will revolutionize the MRI Market and NMR Market!
- US patent, 7,791,343
- Korea patent, 10-1092345, issued on Dec. 5, 2011
- EP 2,173,247, issued on Oct. 3, 2012. Registered in Germany, Netherlands, Italy, UK, and France.
- CN1,258,335, issued on August 21, 2013
- JP5,792,462, issued on August 14, 2015.
